Figure 7
From: Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
PPARγ transcriptional activity in control untreated NB cells (C), in cells treated with RGZ (20 μ M) and in cells transfected with PPARγ in the absence or in the presence of RGZ. L/C: peroxisome proliferator response element-n73-tk-luciferase reporter activity, normalised for CAT activity. *P<0.05 vs C. **P<0.05 vs PPARγ transfected cells in the absence of RGZ.
